Retatrutide HSA/FSA: Can You Use Your Funds Yet?
By The RX Index Editorial Team · Last verified October 17, 2026
No for commercial retatrutide purchases. Retatrutide isn't FDA-approved, federal law bars compounding it, and IRS rules require legally obtained medicine. An HSA/FSA card that goes through doesn't change that. Separately billed care in a lawful trial or Lilly's early access program may qualify; Lilly supplies the early-access drug at no cost.
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
So the real question is what to do with your money while you wait. Your HSA can wait for retatrutide. Your FSA mostly can't. And if you already swiped your card, there are steps to take. The table below sorts it out bill by bill.
RX Index Decision Verdict: Keep anything sold as retatrutide out of your HSA and FSA. Save HSA money for later, and spend FSA money on care that qualifies now.
- Best for: anyone with HSA or FSA money who's waiting for retatrutide, has been offered it, or already paid for it with a benefits card.
- Not ideal for: anyone hoping a prescription, a doctor's letter, or a seller's "HSA/FSA approved" badge will make a retatrutide vial eligible. It won't.
- The factor that matters most: what the bill actually buys.
Quick definitions. An HSA (health savings account) is an account you own for tax-free spending on qualified medical care, and its balance rolls over every year. A health FSA (flexible spending arrangement) is a benefit set up through your job for tax-free spending on qualified medical care, and unused money usually expires at the end of the plan year. A qualified medical expense is a cost the tax rules let either account pay for without tax.
We can't approve your claim. What we can do is show you which facts decide it, which bills to keep separate, and who to ask next.
Retatrutide HSA/FSA check: which expenses qualify
Each bill gets its own answer. A retatrutide product, a doctor visit, and a lab test are separate expenses, and one qualifying doesn't make the others qualify. You also can't claim anything that insurance, a study sponsor, or another account already paid.
| What the bill is for | Is it a qualified HSA/FSA expense today? | Why | What to do |
|---|---|---|---|
| A vial sold online as "research use only" or "not for human consumption" | No | FDA has warned sellers who market retatrutide this way to people (FDA). Tax rules count only medicine that's "legally procured" (26 CFR 1.213-1(e)(2)). | Don't buy it with benefits money. Already did? See the steps below. |
| "Compounded retatrutide" from a clinic, med spa, telehealth site, or pharmacy | No | FDA says retatrutide "cannot be used in compounding under federal law" (FDA). A prescription doesn't fix that. | Don't rely on the seller's payment claim. |
| Retatrutide ordered from an overseas pharmacy or website | No | It isn't FDA-approved and cannot be legally sold for human use. IRS rules generally exclude prescribed drugs shipped in from another country unless they were legally imported (IRS Pub. 502). | Don't. See our guide to spotting fake GLP-1s. |
| The retatrutide drug supplied through Lilly's early access program | No drug expense to claim | Lilly says it "provides products at no cost" through the program (Lilly Medical). | Ask your doctor's office for a written list of any costs that would be yours. |
| Doctor visits or lab tests you pay for in a lawful trial or early access | Maybe | Medical visits and "laboratory fees that are part of medical care" can count (IRS Pub. 502). Each bill is reviewed on its own. | Keep the itemized bill. Note anything a sponsor or insurer paid. |
| One monthly fee that bundles a drug, visits, coaching, or an app | Unclear until itemized | Each part gets judged on its own. Splitting the bill can't turn a retatrutide charge into a "consultation." | Ask for an honest itemized bill. Never relabel the drug charge. |
| An FDA-approved GLP-1 (like Zepbound or Wegovy) prescribed to treat a diagnosed condition | Generally yes | Weight-loss treatment counts when it treats a disease a doctor diagnosed, such as obesity (IRS Pub. 502). Your plan's rules and records still apply. | See "What your HSA or FSA can pay for now" below. |
| Retatrutide after a future FDA approval | Not yet | Lilly plans to submit retatrutide to FDA in the first quarter of 2027 (Lilly). No approval date exists. | Recheck after approval. Don't buy now and plan to claim later. |
This table applies FDA's current statements and general IRS rules to each kind of bill. We did not find an IRS ruling that names retatrutide, so this is our reading of the rules, checked October 17, 2026, not a ruling on your account.
Already paid with your card? Jump to what to do next.
If you're ready to look at what you can start now, the right GLP-1 path isn't the same for everyone. It depends on your state, your insurance and its drug list, whether you want an FDA-approved or compounded medicine, a shot or a pill, and your budget. The RX Index's Find My GLP-1 Path tool asks a few quick questions (free, about 2 minutes, no signup) and shows the GLP-1 paths and providers that fit your goals, budget, insurance, and situation. It won't tell you whether your HSA or FSA will pay.
Why a card that goes through doesn't prove anything
Your benefits card working at checkout is a payment event, not a tax ruling. HSA owners are responsible for showing their withdrawals paid for qualified expenses, and FSA card charges can still be reviewed and reversed later. A seller's "HSA/FSA approved" badge is marketing, not a decision.
Three different things get mashed together here:
- The store took your card. That depends on how the seller set up its payments.
- The expense qualifies. That depends on the tax rules and the facts of the bill.
- Insurance covers it. That's a third question, answered by your health plan.
None of these proves the other two. A qualified prescription can still be an HSA/FSA expense even if your health plan won't cover it (IRS Pub. 969).
Think of an HSA card like a company credit card. The card might work at a casino. That doesn't mean your boss will sign off on the charge.
Your HSA company is not required to decide whether the charge qualifies (IRS Notice 2004-2, Q29). The IRS says you must keep records showing your withdrawals paid for qualified medical expenses (IRS Pub. 969). A nonqualified withdrawal is generally taxable income, plus an extra 20% tax unless it was made after age 65, disability, or the account owner's death.
With an FSA, your plan can ask for proof after the swipe. If the charge doesn't qualify, the plan will want the money back. (IRS Rev. Rul. 2003-43)
Say a med spa page says "Retatrutide Treatment — HSA/FSA accepted," and your card goes through. Nothing about that tells you the expense qualifies. And since FDA says retatrutide can't be compounded under federal law, the offer itself is a red flag.
Does a prescription or a doctor's letter make it eligible?
No. A prescription or a letter of medical necessity can show why you need care, but it can't make an illegal product legal. IRS rules exclude illegal treatments "whether rendered or prescribed by licensed or unlicensed practitioners." (IRS Pub. 502)
A letter of medical necessity is a note from your clinician explaining why a treatment is medically needed. It helps with real treatments that need extra paperwork. It can't fix the retatrutide problem, because the problem isn't missing paperwork. It's that the product can't be legally sold for human use right now. Lilly says this plainly: retatrutide "cannot be legally sold or marketed for human use" (Lilly).
Is FDA approval the whole test?
No. HSA and FSA money can pay for more than FDA-approved prescription drugs. Some over-the-counter medicines count, and lawfully obtained compounded prescriptions can too. The problem here is that commercial retatrutide cannot be legally sold for human use. (IRS Pub. 969; 26 CFR 1.213-1)
You'll read online that "HSAs only pay for FDA-approved drugs." That's not the rule. It also isn't a loophole for retatrutide. For the compounded semaglutide and tirzepatide question, see are compounded GLP-1s HSA/FSA eligible.
Your HSA can wait for retatrutide. Your FSA mostly can't.
HSA money rolls over every year, so you don't lose it just because the year ends. Health FSA money usually has to be used by the end of the plan year. At most you get a grace period of up to 2½ months, or a carryover capped at $680 out of a 2026 plan year, and your plan can offer one or the other, not both. (IRS Pub. 969; Rev. Proc. 2025-32)
Lilly's published plan is to submit retatrutide to FDA in the first quarter of 2027. That's not an approval date. So don't build your 2026 FSA plans around it.
| Question | HSA | Health FSA |
|---|---|---|
| Can the money wait for retatrutide? | Yes. It rolls over. | Mostly no. It's use-it-or-lose-it, apart from any grace period or carryover. |
| Who decides if a bill qualifies? | You are responsible for the tax treatment and records. The HSA company isn't required to decide. | Your plan reviews claims and can ask for proof. |
| Timing rule | The expense must happen after the HSA was opened. | The care must happen during the plan's coverage period. An FSA "can't make advance reimbursements of future or projected expenses." |
| Can you prepay future care now? | Paying early doesn't make future care qualify early. | No. Prepaying in December doesn't make next year's care a December expense. |
| Not sure which account you have? | Check the account name in your benefits portal. | Ask HR whether it's a general, limited-purpose, or post-deductible FSA. |
Sources: IRS Pub. 969 (2025 edition), checked October 17, 2026.
Three account types trip people up. A limited-purpose FSA usually covers only dental and vision. A post-deductible FSA can cover eligible medical costs after its required deductible is met. That deductible may differ from your health plan's deductible. Ask the administrator when eligible prescriptions can be reimbursed. A dependent care FSA is for child or elder care, not medicine.
A worked example (made up, to show the math): Say it's mid-October. You have $1,200 left in a calendar-year FSA, and your plan allows the $680 carryover. You need at least $520 in eligible expenses incurred by December 31 to avoid losing that amount ($1,200 − $680 = $520). Submit the claims by your plan's filing deadline. The $680 moves into 2027 under this plan. Any later carryover depends on the plan's rules. A future retatrutide purchase would still need to qualify when made (IRS Notice 2013-71, Example 4).
If your plan's carryover or grace period is "not sure," treat the whole balance as at risk until HR tells you otherwise. Unknown isn't zero.
Picking 2027 benefits right now? Don't size an FSA around retatrutide. There's no approval date and no official retail price. For what's known so far, see our retatrutide cost predictions. If you want to save for it, an HSA is the account built for waiting. Existing HSA money can wait even if you're no longer eligible to add more. Check your eligibility before planning new contributions. More on deadlines in our FSA grace period and rollover guide.
What to check before you pay
Name the account, name the exact charge, and get an itemized bill before money moves. Then confirm what you personally owe, any discount program's payment rules, and which date the expense falls on. A receipt proves you paid, not that the expense qualifies.
- Name the account. HSA, general health FSA, limited-purpose FSA, post-deductible FSA, or HRA (health reimbursement arrangement)? If you don't know, check the portal or ask HR before claiming anything.
- Name the exact charge. A retatrutide product? A doctor visit? A lab test? An approved prescription? A bundle? "Weight-loss program" alone isn't enough detail.
- Get an itemized bill. Each product or service should be listed and priced on its own line, with the provider, date, and amount.
- Know who's paying. Subtract anything a sponsor, insurer, refund, or other account covers. You can't claim the same dollar twice.
- Use the right reviewer. An FSA administrator reviews FSA claims. For an HSA, you're responsible. Ask your HSA company about procedures, and a tax professional about a gray area. Ask the pharmacy which discount program applies and the manufacturer about its payment restrictions.
- Check the date. An HSA expense must come after the account was opened. An FSA expense must fall inside the coverage period.
Copy this for your FSA administrator (for a real, separate medical bill):
Please confirm what type of health FSA I have and review this exact expense: [service or prescribed medicine], from [provider], on [date], for [amount]. Which documents do you need, which coverage period applies, and is any part of the bill excluded? I'm asking about the itemized charge, not a seller's HSA/FSA badge.
Already paid with your HSA or FSA? Here's what to do
Keep every document and contact the company that runs the account you used. An FSA charge goes back to your plan administrator for review. An HSA withdrawal may be returnable as a "mistaken distribution," but only under specific IRS conditions. (IRS 1099-SA instructions)
First, take a breath. Start by finding out which correction process applies.
Save the original invoice, the product description exactly as the seller wrote it, the transaction date, and any emails. Don't edit, rename, or resubmit a charge to make it look like something else. That turns an honest mistake into a real problem.
If you used an FSA
Ask your FSA administrator to review the charge and tell you how to correct it. Plans can require repayment or other correction for a card charge that doesn't qualify.
Send the real invoice. Ask what they need, what their decision means, and how to repay if needed. Follow their written steps. The HSA's 20% extra tax doesn't apply to FSAs. Your plan's own rules do.
If you used an HSA
Ask your HSA company whether it accepts returns of mistaken distributions. The IRS allows repayment when money came out "because of a mistake of fact due to reasonable cause," by the tax-return due date (not counting extensions) following the first year you knew or should have known it was a mistake. (IRS 1099-SA instructions)
A mistaken distribution is an HSA withdrawal made because of a reasonable mistake of fact. Give the company the original bill and explain what happened; a seller's badge alone does not establish that the repayment rules apply. HSA companies aren't required to accept these repayments, so ask (IRS Notice 2004-50, Q76). Follow the company's correction process; this repayment is not an ordinary HSA contribution.
If the expense does not qualify and the withdrawal is not corrected, the withdrawal is generally taxable income. You may also owe an extra 20% unless the distribution was made after age 65, disability, or the account owner's death (IRS Pub. 969). Those exceptions remove the extra tax, not necessarily the income tax. A tax professional can tell you how to report it.
Copy this for your HSA company:
I may have taken a mistaken HSA distribution for [accurate description] on [date]. Do you accept returns of mistaken distributions? Please tell me the conditions, deadline, documents, and how the correction is reported.
Copy this for a tax professional:
Please review the tax treatment of this HSA distribution. Attached are the itemized bill, the product or service description exactly as sold, the date, and any insurer or sponsor payments. I need to know whether it qualifies and, if not, how to correct or report it.
If you used something sold as retatrutide and feel unwell, call your doctor. For an emergency, call 911. For questions about an unknown product, call Poison Control at 1-800-222-1222.
In a trial or Lilly's early access? What your HSA can pay for
A Lilly trial or Lilly's expanded access program is a legal way to get retatrutide, and it's very different from buying a vial online. Lilly says it supplies the drug at no cost through expanded access, so there's no drug bill to claim. Medical bills you pay yourself can be reviewed separately. (Lilly Medical)
Lilly's expanded access program (also called early access or compassionate use) is narrow. Your treating doctor has to request it, and you must meet strict criteria, including a body mass index (BMI) of 35 or more and two or more serious weight-related conditions under treatment. Our retatrutide early access guide walks through all five rules.
| Cost | Who usually pays | Can it qualify for HSA/FSA reimbursement? |
|---|---|---|
| The drug (expanded access) | Lilly, at no cost | Nothing to claim |
| The drug (clinical trial) | Confirm with the study team | Nothing to claim if the study supplies it at no cost |
| Doctor visits you pay for | You | Generally yes, if it's medical care you paid out of pocket |
| Lab tests you pay for | You | Generally yes ("laboratory fees that are part of medical care") |
| Ethics review board fees | Depends on the board | Ask your FSA administrator or, for an HSA, a tax professional; eligibility is not established here |
| Travel to care | You | Possibly, if it's "primarily for and essential to medical care"; lodging limits apply |
Sources: Lilly Medical (last reviewed August 26, 2026); IRS Pub. 502. Checked October 17, 2026.
Don't assume every trial visit is free, or that every trip or hotel counts. Ask the trial team or your doctor's office which costs could land on you, and whether anyone else will reimburse them. For the bigger access picture, see current retatrutide access paths and our retatrutide clinical trials tracker.
What your HSA or FSA can pay for now
FDA-approved GLP-1s like Zepbound (tirzepatide, also made by Lilly) and Wegovy can be paid for with HSA or FSA money when they're prescribed to treat a diagnosed condition, such as obesity. Lawfully compounded semaglutide or tirzepatide prescribed for medical care may also qualify, but they're not FDA-approved and they're not retatrutide. FDA says compounded drugs should be used only when a patient's medical needs cannot be met by an FDA-approved drug. (IRS Pub. 502; FDA)
| Your situation | Good first step | What to confirm |
|---|---|---|
| You already have a doctor who prescribes | Ask about an available, approved option and what the pharmacy will charge | The exact prescription, what you pay, and your account's rules |
| You want an FDA-approved option online, with insurance help | Ro (details below) | Membership and medicine are separate charges; Ro supplies documents for possible reimbursement and does not accept HSA/FSA cards directly |
| Your clinician identifies a need for compounded treatment that an FDA-approved medicine cannot meet | Embody (details below) | Confirm the medical need, lawful pharmacy supply, full price, and itemized receipt; compounded isn't FDA-approved |
| You're still sorting it out | Find My GLP-1 Path | It suggests paths and providers; it doesn't check your coverage or tax rules |
Under 18, pregnant or planning a pregnancy, living with type 1 diabetes, or have a history of an eating disorder? Talk with your own clinician before any GLP-1 program.
If you want an FDA-approved option: Ro
Ro offers FDA-approved GLP-1s, including the Zepbound KwikPen, the Wegovy pill and pen, and the Foundayo pill, through its Ro Body membership. Ro says it can't take HSA or FSA cards, but it gives you a detailed receipt and a prescription copy to submit for possible reimbursement. (Ro Help Center)
Ro does not offer retatrutide. Here's the catch, up front. You pay Ro with a regular card. If the charge qualifies and the offer allows it, you can reimburse yourself from your HSA or submit an FSA claim. If swiping your benefits card matters most, a pharmacy that takes it is simpler. Ro's membership and medication charges are separate, which helps you review each expense. A receipt supports the review; it does not establish eligibility. Ro's insurance help currently covers the Wegovy pen, Zepbound autoinjector pen, and Ozempic. The pill and KwikPen prices below are cash-pay prices (Ro insurance).
| Ro charge (checked October 17, 2026) | Price |
|---|---|
| Membership, first month | $39, refunded if you're not eligible for GLP-1s |
| Membership, after the first month | $149 paid monthly; $297 prepaid every 3 months ($99/month); $534 prepaid every 6 months ($89/month); or $888 prepaid annually ($74/month) |
| Zepbound KwikPen (medicine, billed separately; 28-day supply) | $299 at 2.5 mg; $399 at 5 mg; $449 at 7.5–15 mg under the refill offer explained below |
| Wegovy pill (medicine, billed separately; 30-day supply) | $149 at 1.5 mg; $199 at 4 mg; $299 at 9 mg or 25 mg |
| Foundayo pill (medicine, billed separately; 30-day supply) | $149 at 0.8 mg; higher-dose prices and offer limits are explained below |
Source: Ro pricing, checked October 17, 2026. Medicine prices are separate from membership. A clinician decides if a medicine is right for you.
The $149 pill price is a starting-dose price. For Foundayo, the offer prices are $149 at 2.5 mg and $199 at 5.5 mg through December 31, 2026; the regular prices are $199 and $299. At 9 mg, the price is $299. At 14.5 mg or 17.2 mg, it's $299 with the refill offer or $349 without it. That offer requires the next refill purchase within 45 days of the last delivery; Ro asks for a refill check-in within that window (Ro; Lilly terms).
The $449 KwikPen price has a refill deadline. Ro says to complete its refill check-in within 45 days of the last delivery. Lilly's offer requires the next refill purchase within that 45-day window. Miss it and Ro lists $499 for 7.5 mg or $699 for 10–15 mg. Pen needles cost extra (Ro Zepbound pricing; Lilly terms; LillyDirect).
Check the exact discount program, too. Lilly's separate Self-Pay Savings Card terms for KwikPen and Foundayo bar payment or reimbursement of your own costs from a "healthcare reimbursement account." Those cards expire December 31, 2026. Novo Nordisk's Wegovy self-pay offer has a similar account-reimbursement restriction.
LillyDirect separately labels KwikPen and Foundayo HSA/FSA eligible, depending on the plan. Ask the dispensing pharmacy which program your fill uses, and get written clarification from the manufacturer about HSA/FSA use before paying. The tax rule and the offer's payment rules are separate questions.
The membership includes clinician support, check-ins, coaching, help with insurance paperwork, and lab testing if needed. Ro's terms allow extra charges: $15 per visit after 24 medical visits in a year, plus fees for additional lab tests. Medicine costs extra (Ro terms).
Ro's membership renews automatically. Its terms say paid membership fees are nonrefundable; the first-month refund if you're not eligible is a separate exception. Cancel at least 48 hours before renewal to stop the next charge. You keep membership services through the period you already paid for. Check the full term and renewal amount before choosing a prepaid plan (Ro terms, revised April 2, 2026).
Check the medicine and the membership separately with your account. A prescription bill identifies the medicine you paid for. Ask your FSA administrator what it needs for any program fee; the whole membership is not automatically eligible. Our guide to how Ro's HSA/FSA payment process works covers the receipts step by step.
Have Medicaid? Start with your own plan and doctor; Ro says Medicaid patients aren't currently eligible for its program. See our Zepbound HSA/FSA guide for that drug's account rules.
If you want to review an FDA-approved prescription option with a clinician and insurance help in one place, Ro is a strong place to start. Check the exact charges for HSA/FSA eligibility before committing. Get started for $39, then as low as $74/month with the annual plan paid upfront ($888). Medicine costs extra.
Review Ro's GLP-1 options and pricing
If your clinician recommends a compounded option: Embody
Embody is a cash-pay program for compounded semaglutide and tirzepatide, with no separate membership fee. Its homepage labels its GLP-1 plans "HSA/FSA Approved." Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they reach patients. (Embody; FDA)
If cost brought you here, first ask your clinician whether an FDA-approved option can meet your medical needs. If your clinician identifies a need for compounded treatment, Embody's one-month compounded semaglutide supply showed a $79 sale price on October 17, 2026 (regular price listed at $299). The product page lists medication, clinician review, support, and shipping as included. A clinician reviews your history after checkout, before anything is prescribed. The program may not be available in your state.
The renewal price needs a written answer. The $79 product offer does not match Embody's published Start program terms: $99 for the first month of semaglutide injections, then $299 a month. Its homepage and the offer linked below advertise $69 a month. We could not confirm which renewal price applies to the $79 offer. Ask Embody for the amount due now, the next charge and date, any lab fees, and the plan term before paying (product page; terms).
Two honest notes. First, this isn't retatrutide, and it isn't FDA-approved Wegovy or Zepbound. Second, Embody's badge doesn't settle your account's rules. Its refund policy says the price is a bundle, without separate prices for each service, shipment, or month. With an FSA, check when the medicine will be supplied and services will be provided. Ask Embody for the receipt your administrator needs, and get the administrator's answer on that bundle before paying. Our Embody HSA/FSA guide has the full checklist.
Embody charges at checkout and renews automatically. Cancellation must arrive at least 72 hours before the next billing date. Payments aren't refundable unless a provider rules that you are not medically eligible. Even then, Embody subtracts the cost of services already used. Read the cancellation and refund terms before choosing a plan.
If your clinician recommends compounded treatment for a need an FDA-approved medicine cannot meet, review Embody's current offer. Get its full price and receipt terms in writing before paying:
Will retatrutide be HSA/FSA eligible after FDA approval?
After FDA approval and lawful sale, the usual prescription-expense rules would apply. Each bill would still need to meet them. Lilly's published plan is to submit retatrutide to FDA in the first quarter of 2027, and no approval date has been set. (Lilly)
After approval, the usual questions would decide it: Was it prescribed to treat a diagnosed condition? Was it bought legally? What did you actually pay? What does your plan allow?
A future approval won't reach back and fix a purchase made today. A research vial bought in 2026 stays a research vial. For the latest, see retatrutide news today and how it compares with tirzepatide.
What we actually verified
We checked FDA's current retatrutide and compounding statements, the approved medicines' prescribing information, the IRS rules and regulation text that decide HSA and FSA expenses, Lilly's early access page, manufacturer discount terms, and Ro's and Embody's public payment, pricing, and terms pages. We did not test a card, file a claim, buy anything, or get an IRS ruling on any account.
| Checked October 17, 2026 | What it shows | What it doesn't show |
|---|---|---|
| FDA unapproved GLP-1 page (content current as of October 1, 2026) | Retatrutide can't be compounded under federal law; warnings on "research" products | An IRS ruling |
| Lilly release, July 23, 2026 | Not approved; planned FDA submission Q1 2027 | An approval date or price |
| Lilly Medical early access page (last reviewed August 26, 2026) | Physician-requested program; drug provided at no cost | Admission or free related care |
| IRS Pub. 502, Pub. 969, 26 CFR 1.213-1, 1099-SA instructions | Legality, timing, records, penalties, mistaken-distribution rule | A ruling on your claim |
| Ro pricing, Ro terms, Ro HSA/FSA help, Lilly offer terms, Wegovy offer terms, Embody product, terms, and refund policy | Published prices, refill and payment rules, cancellation limits, and the Embody price conflict | A confirmed renewal price for Embody's $79 offer, which discount program applies to your fill, or that your plan will reimburse the charge |
Read how we evaluate treatment paths.
Retatrutide HSA/FSA FAQ
Can I buy retatrutide with money from my HSA?
No for ordinary commercial retatrutide purchases: IRS rules count only medicine that's legally obtained. A nonqualified withdrawal is generally taxable and may carry an extra 20% tax. The extra tax does not apply to distributions made after age 65, disability, or the account owner's death.
If a clinic takes my HSA or FSA card for retatrutide, does that mean it qualifies?
No. A card going through is a payment event, not a tax ruling. HSA owners must prove withdrawals paid for qualified expenses, and FSA plans can review and reverse card charges later.
Should I spend my HSA on Zepbound now or wait for retatrutide?
Which medicine fits you is a decision for you and your clinician. Money-wise, an HSA lets you do either: Zepbound can be a qualified expense when prescribed for a diagnosed condition, and unspent HSA dollars roll over for later.
Is retatrutide FSA eligible?
Not for commercial retatrutide purchases today. Don't plan your current FSA spending around an unapproved medicine. Your plan may offer a grace period of up to 2½ months or a carryover—up to $680 from a 2026 plan year—but it cannot offer both for the same health FSA.
Does a prescription or doctor's letter make retatrutide eligible?
No. IRS rules exclude illegal treatments even when a licensed practitioner prescribes them. A letter helps with real treatments that need paperwork, but it can't make an illegal product eligible.
Can I use my HSA for needles and alcohol pads I use with retatrutide?
Don't assume so. Supplies count only when they're used for medical care, and the tax rules exclude illegal treatments. A store's "HSA-eligible" tag on syringes doesn't settle what they're being used for. Ask a tax professional.
Can I claim the consultation or lab work instead?
Possibly, if it's real medical care you paid for yourself and it fits your account's rules. Relabeling a retatrutide charge as a "consultation" doesn't change what you bought, and it can create a bigger problem.
Is retatrutide free in Lilly's early access program?
Lilly says it provides the drug at no cost through the program. Doctor visits, labs, ethics review, and travel can still cost money, so ask your doctor's office which costs would be yours.
What if I already paid for "reta" with my HSA or FSA?
For an FSA, ask your plan administrator to review the charge and explain the correction. For an HSA, ask your HSA company about returning a mistaken distribution, and talk to a tax professional. Keep every document, and never relabel the charge.
Can I buy retatrutide now and claim it after it's approved?
No. A future approval won't make today's purchase legal. What matters is what you bought, when, and from whom.
Can I prepay future care with leftover FSA money?
No. The IRS says an FSA can't make advance reimbursements of future or projected expenses. Paying in December doesn't make next year's care a December expense.
Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.
Sources
All checked October 17, 2026. Dates in parentheses belong to the source.
- FDA — Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of October 1, 2026)
- Eli Lilly — Retatrutide successful in two additional Phase 3 obesity trials (July 23, 2026)
- Lilly Medical — Is there an expanded access program for retatrutide? (last reviewed August 26, 2026)
- eCFR — 26 CFR 1.213-1, Medical, dental, etc., expenses (current as of October 15, 2026)
- IRS — Publication 502, Medical and Dental Expenses (2025)
- IRS — Publication 969, Health Savings Accounts and Other Tax-Favored Health Plans (2025)
- IRS — Revenue Procedure 2025-32 (2026 health FSA limits)
- IRS — Instructions for Forms 1099-SA and 5498-SA (2025 instructions; HSA mistaken distributions)
- Ro — Can I use my HSA or FSA card?
- Ro — Weight loss program pricing and insurance
- Embody — Homepage and compounded semaglutide one-month supply
- IRS — Notice 2004-2, Q29 (HSA custodian responsibility)
- IRS — Notice 2004-50, Q39 and Q76 (HSA reimbursement timing and mistaken-distribution repayments)
- IRS — Revenue Ruling 2003-43 (FSA card substantiation and corrections)
- IRS — Notice 2013-71, Example 4 (carryover into later plan years)
- FDA — Compounding policies as GLP-1 supply stabilizes (April 1, 2026 update)
- Eli Lilly — Zepbound prescribing information (revised August 2026) and Foundayo prescribing information (revised July 2026)
- Novo Nordisk — Wegovy prescribing information (revised June 2026)
- Embody — Terms & Conditions (last updated April 24, 2026) and Cancellation & Refund Policy (last updated August 25, 2026)
- HRSA — About Poison Help (Poison Control contact number)
- Ro — Terms and Conditions of Use (revised April 2, 2026) and Zepbound pricing and refill rules
- Eli Lilly — Zepbound savings terms and LillyDirect Zepbound prices (purchase-offer conditions and self-pay savings card ending December 31, 2026)
- Ro — How to get retatrutide (updated August 27, 2026)
- Embody — Current offer page (advertised $69 semaglutide offer)
- Ro — Foundayo pricing and refill rules; Eli Lilly — Foundayo coverage and savings terms and LillyDirect Foundayo prices (30-day supplies; temporary 2.5 mg and 5.5 mg prices through December 31, 2026)
- Novo Nordisk — Wegovy savings and prices and savings-offer terms (30-day tablet supplies; self-pay offer payment restrictions)